Moreover, the suppression of DAPK1 has been shown to reduce ischemic brain injury by inhibiting cell death signaling and promoting neural remodeling, which could have parallels in renal tissue, suggesting a potential for therapeutic interventions targeting DAPK1 in ischemic kidney injury (99). This evidence concerns the gene DAPK1 and kidney injury.